Citations

Showing 10 of 108104 citations.

Medical liability in the electronic medical records era
Paterick, Zachary R., Patel, Nachiket , Ngo, Elizabeth, Chandrasekaran, Krishnaswamy , Paterick, Timothy E. , Patel, Nachiket J , Tajik, A. Jamil

Mayo Clinic

Baylor University Medical Center Proceedings | September 11, 2018 | Volume: 31 | Issue: 4 | Pages: 558-561

10.1080/08998280.2018.1471899 | PMID 30949012 Get It

MOG antibodies in combined central and peripheral demyelination syndromes
Campo, Rocio Vazquez Do , Stephens, Alana, Collazo, I. Vanessa Marin , Rubin, Devon I., Vazquez do Campo, Rocio, Marin Collazo, I Vanessa, Vazquez Do Campo, Rocio

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | September 11, 2018 | Volume: 5 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000000503 | PMID 30246057 Get It

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048
Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. , Minasian, Lori M. , Denicoff, Andrea , Wind, Jennifer, Shaw, Mary, Heon, Narre , Shi, Qian , Ginos, Brenda, Nelson, Garth D. , Meyers, Jeffrey P., Chang, George J. , Mamon, Harvey J. , Weiser, Martin R. , Kolevska, Tatjana , Bruner, Deborah Watkins , Denicoff, Andrea M, Wind, Jennifer K, Shaw, Mary C, Schrag, Deborah , Dueck, A. C. , Bruner, Deborah , Shi, Qian , Basch, Ethan , Mitchell, Sandra A , Shaw, Mary C., Reeve, Bryce B. , Schrag, Deborah

Mayo Clinic

Journal of Clinical Oncology | September 11, 2018 | Volume: 36 | Issue: 31 | Pages: 3120-3125

10.1200/jco.2018.78.8620 | PMID 30204536 Get It

Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable patient reporting of symptomatic adverse events in oncology clinical research. This study was designed to assess the feasibility and resource requirements associated with implementing PRO-CTCAE in a multicenter trial. Methods Patients with locally advanced rectal cancer enrolled in the National Cancer Institute–sponsored North Central Cancer Treatment Group (Alliance) Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and Total Mesorectal Excision trial were asked to self-report 30 PRO-CTCAE items weekly from home during preoperative therapy, and every 6 months after surgery, via either the Web or an automated telephone system. If participants did not self-report within 3 days, a central coordinator called them to complete the items. Compliance was defined as the proportion of participants who completed PRO-CTCAE assessments at expected time points. Results The prespecified PRO-CTCAE analysis was conducted after the 500th patient completed the 6-month follow-up (median age, 56 years; 33% female; 12% nonwhite; 43% high school education or less; 5% Spanish speaking), across 165 sites. PRO-CTCAE was reported by participants at 4,491 of 4,882 expected preoperative time points (92.0% compliance), of which 3,771 (77.2%) were self-reported by participants and 720 (14.7%) were collected via central coordinator backup. Compliance at 6-month post-treatment follow-up was 333 of 468 (71.2%), with 122 (26.1%) via backup. Site research associates spent a median of 15 minutes on PRO-CTCAE work for each patient visit. Work by a central coordinator required a 50% time commitment. Conclusion Home-based reporting of PRO-CTCAE in a multicenter trial is feasible, with high patient compliance and low site administrative requirements. PRO-CTCAE data capture is improved through centralized backup calls.
Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex
Brown‐Elliott, Barbara A. , Simmer, Patricia J., Trovato, Alberto , Hyle, Emily P. , Droz, Sara, Buckwalter, Seanne P., Borroni, Emanuele , Branda, John A. , Iana, Elkina, Mariottini, Alessandro , Nelson, Jameelah, Toney, Nadege C. , Scarparo, Claudio, Man, Tom J. B. de , Vasireddy, Ravikiran, Gandhi, Rajesh T. , Wengenack, Nancy L. , Wallace, Richard J. , Matteelli, Alberto , Cirillo, Daniela María , Tortoli, Enrico

Mayo Clinic

International Journal of Systematic and Evolutionary Microbiology | September 11, 2018 | Volume: 68 | Issue: 11 | Pages: 3557-3562

10.1099/ijsem.0.003031 | PMID 30204586 Get It

Population-based study of “no evident disease activity” in MS
Parks, Natalie, Pittock, Sean J. , Mandrekar, Jay , Kantarci, Orhun H. , Lucchinetti, Claudia F. , Weinshenker, Brian G. , Tillema, Jan‐Mendelt , Toledano, Michel , Parks, Natalie E, Pittock, S J , Weinshenker, Brian G , Keegan, B. Mark , Tobin, W. Oliver , Flanagan, Eoin P.

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | September 11, 2018 | Volume: 5 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000000495 | PMID 30211251 Get It

Comparison of two FDA-cleared EIA assays for the detection of Coccidioides antibodies against a composite clinical standard
Grys, Thomas E. , Brighton, Anjuli, Liesman, Rachael M. , LaSalle, Cassie Bolster, Blair, Janis E. , Bolster LaSalle, Cassie, Grys, Thomas E , Chang, Yu‐Hui

Mayo Clinic

Medical Mycology | September 11, 2018 | Volume: 57 | Issue: 5 | Pages: 595-600

10.1093/mmy/myy094 | PMID 30329094 Get It

Breast Cancer Screening: Women's Attitudes and Beliefs in Light of Updated United States Preventive Services Task Force and American Cancer Society Guidelines
Mehta, Jaya , MacLaughlin, Kathy L. , Millstine, Denise , Wallace, Mark R. , Shah, Amit , Fields, Heather , Ruddy, Barbara E., Bryan, Michael , Patel, Bhavika , Temkit, M’hamed , Buras, Matthew , Golafshar, Michael A. , Kling, Juliana M. , Mehta, Jaya M, Millstine, Denise M, Shah, Amit A, Fields, Heather E, Bryan, Michael J, Patel, Bhavika K , Buras, Matthew R , Golafshar, Michael , Kling, Juliana M , Shah, Amit A , Faubion, Stephanie S.

Mayo Clinic

Journal of Women's Health | September 11, 2018 | Volume: 28 | Issue: 3 | Pages: 302-313

10.1089/jwh.2017.6885 | PMID 30204537 Get It

Reactivation of Chagas disease among heart transplant recipients in the United States, 2012‐2016
Gray, Elizabeth B. , Hoz, Ricardo M. La , Green, Jaime S. , Vikram, Holenarasipur R. , Benedict, Theresa, Rivera, Hilda N., Montgomery, Susan P. , Vikram, Holenarasipur R. , La Hoz, Ricardo M

Mayo Clinic

Transplant Infectious Disease | September 11, 2018 | Volume: 20 | Issue: 6 | Pages: No page available

10.1111/tid.12996 | PMID 30204269 Get It

AbstractBackgroundHeart transplantation has been shown to be a safe and effective intervention for progressive cardiomyopathy from chronic Chagas disease. However, in the presence of the immunosuppression required for heart transplantation, the likelihood of Chagas disease reactivation is significant. Reactivation may cause myocarditis resulting in allograft dysfunction and the rapid onset of congestive heart failure. Reactivation rates have been well documented in Latin America; however, there is a paucity of data regarding the risk in non‐endemic countries.MethodsWe present our experience with 31 patients with chronic Chagas disease who underwent orthotopic heart transplantation in the United States from 2012 to 2016. Patients were monitored following a standard schedule.ResultsOf the 31 patients, 19 (61%) developed evidence of reactivation. Among the 19 patients, a majority (95%) were identified by laboratory monitoring using polymerase chain reaction testing. One patient was identified after the onset of clinical symptoms of reactivation. All subjects with evidence of reactivation were alive at follow‐up (median: 60 weeks).ConclusionsTransplant programs in the United States are encouraged to implement a monitoring program for heart transplant recipients with Chagas disease. Our experience using a preemptive approach of monitoring for Chagas disease reactivation was effective at identifying reactivation before symptoms developed.
Extracting chemical–protein relations using attention-based neural networks
Liu, Sijia , Shen, Feichen , Elayavilli, Ravikumar Komandur, Wang, Yanshan , Chaudhary, Vipin , Komandur Elayavilli, Ravikumar, Rastegar-Mojarad, Majid, Liu, Sijia , Rastegar-Mojarad, Majid , Liu, Hongfang , Wang, Yanshan

Mayo Clinic

Database | September 11, 2018 | Volume: 2018 | Issue: No issue available | Pages: No page available

10.1093/database/bay102 | PMID 30295724 Get It

Aberrant structural–functional coupling in adult cannabis users
Kim, Dae‐Jin , Martin, Ashley M. Schnakenberg , Cheng, Hu , Newman, Sharlene D. , Sporns, Olaf , Hetrick, William P. , Calkins, Eli, O’Donnell, Brian F. , Jo, Hang Joon , Newman, Sharlene D , Shin, Yong‐Wook

Mayo Clinic

Human Brain Mapping | September 11, 2018 | Volume: 40 | Issue: 1 | Pages: 252-261

10.1002/hbm.24369 | PMID 30203892 Get It

AbstractCellular studies indicate that endocannabinoid type‐1 retrograde signaling plays a major role in synaptic plasticity. Disruption of these processes by delta‐9‐tetrahydrocannabinol (THC) could produce alterations either in structural and functional brain connectivity or in their association in cannabis (CB) users. Graph theoretic structural and functional networks were generated with diffusion tensor imaging and resting‐state functional imaging in 37 current CB users and 31 healthy non‐users. The primary outcome measures were coupling between structural and functional connectivity, global network characteristics, association between the coupling and network properties, and measures of rich‐club organization. Structural–functional (SC–FC) coupling was globally preserved showing a positive association in current CB users. However, the users had disrupted associations between SC–FC coupling and network topological characteristics, most perturbed for shorter connections implying region‐specific disruption by CB use. Rich‐club analysis revealed impaired SC–FC coupling in the hippocampus and caudate of users. This study provides evidence of the abnormal SC–FC association in CB users. The effect was predominant in shorter connections of the brain network, suggesting that the impact of CB use or predispositional factors may be most apparent in local interconnections. Notably, the hippocampus and caudate specifically showed aberrant structural and functional coupling. These structures have high CB1 receptor density and may also be associated with changes in learning and habit formation that occur with chronic cannabis use.